Treating multiple sclerosis with fingolimod or intramuscular interferon

Author： Pozzilli Carlo   Prosperini Luca   Borriello Giovanna  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.11, 2010-08, pp. : 1957-1960

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating Relapsing Multiple Sclerosis with Subcutaneous versus Intramuscular Interferon-Beta-1a: Modelling the Clinical and Economic Implications

By Guo Shien   Bozkaya Duygu  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 39-53

Adis International

Access to resources Recommend Favorite

Fingolimod for relapsing multiple sclerosis: an update

By Horga Alejandro   Castilló Joaquín   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1183-1196

Informa Healthcare

Access to resources Recommend Favorite

Fingolimod for the treatment of relapsing multiple sclerosis

By Singer Barry A  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 6, 2013-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite

Fingolimod: Multiple sclerosis relapse: case report

By  

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Fingolimod: Multiple sclerosis relapse: case report

By  

Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite